Marketscreener
Published September 24, 2026
Clearmind Medicine Enhances U.S. IP Presence with Publication of Three Patent ...
Read the full story at Marketscreener
'The publication of these patents come at a significant time as clinical and regulatory interest in LSD , ketamine and ibogaine continues to receive.
Surfaced by this Google Alert
- LSD
